<DOC>
	<DOCNO>NCT00906269</DOCNO>
	<brief_summary>The purpose study determine add hyperbaric oxygen therapy , therapy delivers oxygen slight pressure , drug treatment PDE5I ( Viagra , Levitra , Cialis ) men follow surgery prostate cancer result men able continue erection .</brief_summary>
	<brief_title>Can Hyperbaric Oxygen Improve Erectile Function Following Surgery Prostate Cancer</brief_title>
	<detailed_description>Prostate cancer common non-skin malignancy men United States , approximately 232,000 diagnosis adenocarcinoma projected 2005 . More 150,000 men treat radical prostatectomy . Common sequelae follow successful NSRRP ( nerve-sparing radical retropubic prostatectomy ) include urinary incontinence sexual dysfunction . Recent advance surgery technique treatment make spite aggressive management , recovery sexual function incomplete few one-fifth reporting return baseline . The etiology erectile dysfunction follow radical prostatectomy result probably local surgical trauma neurapraxia , lead corpus cavernosal hypoxemia post-NSRRP period . This hypoxemia believe impact negatively health maintenance smooth muscle cell within corpus cavernosum . Hyperbaric oxygen therapy ( HBO2T ) unique modality able provide oxygen delivery tissue damage traumatic injury . Hypothesis : The addition post-NSRRP hyperbaric oxygen therapy ( HBO2T ) treatment phosphodiesterase type 5 inhibitor ( PDE5I ) reduce incidence erectile dysfunction ( ED ) urinary incontinence measure 1 , 3 , 6 , 12 18 month post-NSRRP Stage I prostate cancer .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>male age 4069 diagnosis Stage I prostate cancer bilateral NSRRP primary treatment sexual potency prior surgery COPD , CHF , diabetes mellitus know inability tolerate PDE5I confinement anxiety/claustrophobia plan adjuvant neoadjuvant therapy patient take alpha blocker nitrate patient retinitis pigmentosa</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>impotence</keyword>
	<keyword>prostatic neoplasm</keyword>
	<keyword>hyperbaric oxygenation</keyword>
	<keyword>Phosphodiesterase Inhibitors</keyword>
</DOC>